Fig 1.
Flow-chart of inclusion and exclusion of study participants.
Fig 2.
Findings and samples documented and collected at each study visit.
Symptom score was based on self-reported symptoms by participants. Examination score was evaluated by the gynaecologist at the gynaecological examination.
Table 1.
Clinical characteristics of the study participants.
Table 2.
Results after acute and prophylactic treatment with either CHG or FLZ.
Fig 3.
Major species shift between gynaecological examinations.
An alluvial representation of the most abundant species per patient sample, across all gynaecological examination timepoints, for treatment with either a chlorhexidine or b fluconazole. CHG: chlorhexidine, FLZ: fluconazole.